Therapeutics to prevent cisplatin-induced hearing loss by transcriptomics
Ended Project Grant Awarded Last action
- Award ID
- R43DC018762
- Recipient
-
Ting Therapeutics, Inc. UEI F5R2ZH3HCHB5
- Awarding agency
-
National Institute on Deafness and Other Communincation Disorders
National Institutes of Health, Department of Health and Human Services
- Obligated
- $200,486
Award facts
- Assistance listing
- 93.173 Research Related to Deafness and Communication Disorders
- Completion date
- Originally
- Place of performance
- Nebraska, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$2,625 | |
| Amendment | -$2,625 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $205,736 |
Quick answers
Who received award R43DC018762?
R43DC018762 was awarded to Ting Therapeutics, Inc. by National Institute on Deafness and Other Communincation Disorders (National Institutes of Health) on April 1, 2020.
How much is award R43DC018762 worth?
$200,486 has been obligated on R43DC018762.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award